These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29766536)

  • 21. Accelerated Stability Assessment Program to Predict Long-term Stability of Drugs: Application to Ascorbic Acid and to a Cyclic Hexapeptide.
    Legrand P; Gahoual R; Houzé P; Dufaÿ S
    AAPS PharmSciTech; 2021 Sep; 22(7):234. PubMed ID: 34498167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine stability study design and analysis to support product licensure.
    Schofield TL
    Biologicals; 2009 Nov; 37(6):387-96; discussion 421-3. PubMed ID: 19717312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humidity-corrected Arrhenius equation: The reference condition approach.
    Naveršnik K; Jurečič R
    Int J Pharm; 2016 Mar; 500(1-2):360-5. PubMed ID: 26802498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Manufacturing Design Space Concepts for Stability Risk Assessment-Gabapentin NIPTE/FDA Case Study.
    Stamatis SD; Kirsch LE
    AAPS PharmSciTech; 2018 Oct; 19(7):2801-2807. PubMed ID: 30120695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of Arrhenius Kinetics to Acceleration of Controlled Extraction Studies.
    Jenke D
    PDA J Pharm Sci Technol; 2019; 73(2):135-169. PubMed ID: 30361282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating shelf-life of drugs in solution.
    Newton DW; Miller KW
    Am J Hosp Pharm; 1987 Jul; 44(7):1633-40. PubMed ID: 3631095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic principles of stability.
    Egan W; Schofield T
    Biologicals; 2009 Nov; 37(6):379-86; discussion 421-3. PubMed ID: 19720547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining shelf life by comparing degradations at elevated temperatures.
    Magari RT; Munoz-Antoni I; Baker J; Flagler DJ
    J Clin Lab Anal; 2004; 18(3):159-64. PubMed ID: 15103679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of drug substance predicted chemical stability with ICH compliant stability studies.
    Williams HE; Bright J; Roddy E; Poulton A; Cosgrove SD; Turner F; Harrison P; Brookes A; MacDougall E; Abbott A; Gordon C
    Drug Dev Ind Pharm; 2019 Mar; 45(3):379-386. PubMed ID: 30395722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic Model Development for Accelerated Stability Studies.
    Clancy D; Hodnett N; Orr R; Owen M; Peterson J
    AAPS PharmSciTech; 2017 May; 18(4):1158-1176. PubMed ID: 27422651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of Accelerated Stability Model Based on the Arrhenius Equation for Shelf Life Estimation of In Vitro Diagnostic Products.
    Ebrahim A; DeVore K; Fischer T
    Clin Chem; 2021 Mar; 67(4):684-688. PubMed ID: 33276380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting stability of lyophilized products.
    Nicholson AE
    Dev Biol Stand; 1976 Oct; 36():69-75. PubMed ID: 1030438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Extrapolation of a Radical Equation More Accurately Predicts Shelf Life of Frozen Biological Matrices.
    De Vore KW; Fatahi NM; Sass JE
    Clin Chem; 2016 Aug; 62(8):1075-83. PubMed ID: 27335077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shelf-life of a 2.5% sodium hypochlorite solution as determined by Arrhenius equation.
    Nicoletti MA; Siqueira EL; Bombana AC; Oliveira GG
    Braz Dent J; 2009; 20(1):27-31. PubMed ID: 19466227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing distributions of estimated drug shelf lives in stability analysis.
    Sun Y; Chow SC; Li G; Chen KW
    Biometrics; 1999 Sep; 55(3):896-9. PubMed ID: 11315024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solution.
    Altan S; Faya P; Rauk AP; LeBlond D; Seaman JW; Banton D
    Pharm Stat; 2023; 22(5):784-796. PubMed ID: 37164770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating Shelf Life Through Tolerance Intervals Extended to Nonlinear Response Trends.
    Schwenke J; Stroup W; Quinlan M; Forenzo P
    AAPS PharmSciTech; 2023 Mar; 24(4):80. PubMed ID: 36944868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
    Campbell GA; Vallejo E
    J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization.
    Novack GD; Evans R
    J Glaucoma; 2001 Dec; 10(6):483-6. PubMed ID: 11740219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.